Experts are stressing the need for education around coronavirus vaccines. Many vaccines currently in development have short-term side effects, like headache, sore arms or fever. Experts say people should be told now that the vaccines may cause discomfort. (STAT)

Global vaccine alliance says $40 should be the maximum cost of a COVID-19 vaccine. The GAVI vaccine alliance has begun looking at potential pricing for a vaccine. The alliance also plans to negotiate lower prices for low-income countries. (Reuters)

Moderna’s COVID-19 vaccine could be ready by the end of the year, said company leaders and U.S. officials. The company began enrolling for its late-stage trial of the vaccine, which will test it on 30,000 patients. (Reuters)

AstraZeneca to pay up to $6 billion for Daiichi Sankyo cancer drug. The two companies will collaborate to develop and market a new type of experimental cancer treatment called antibody drug conjugates. (Reuters)

Ro has raised $200 million in financing as it expands its telehealth model. The health startup is now valued at $1.5 billion. The company said it has reached 5 million patient-physician interactions. (CNBC)